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Modified asparaginase, in which 4 tryptophan residues were modified with 2-hydroxy-S-nitrobenzyl bro- 
mide, had little enzymic activity and retained immunoreactivity ((1976) FEBS Lett. 65, 11-t 51. Addition 
of IgG or its Fab towards asparaginase to the modified asparaginase gave rise to marked enhancement of 
the enzymic activity. Native asparaginase (4 subunits) lost the enzymic activity due to dissociation into sub- 
units by dilution of the enzyme solution. However. in the presence of Fab, asparaginase did not lose enzymic 
activity on dilution, probably due to no dissociation into subunits occurring. 
Asparaginase 2-Hydroxy-Snitrobenzyl bromide Anit-asparaginase IgG 
1. INTRODUCTION 
Celada et al. [l-3] demonstrated the activation 
of mutant /3-galactosidase by its antibodies, and 
Melchers and Messer [4] reported the protection 
from thermal denaturation of ,&galactosidase with 
its antibodies. These phenomena have been ex- 
plained by the alternation or protection of protein 
conformation due to interaction of enzyme with 
specific antibodies 151. 
In a previous study [6], it was found that 4 tryp- 
tophan residues in the asparaginase molecule from 
E. coli (M, 1360~, 4 identical subunits) were 
specifically modified with 2-hydroxy-5-nitrobenzyl 
bromide (HNB). This study deals with activation 
of HNB-modified asparaginase together with 
stabilization of native asparaginase by IgG or its 
Fab towards native asparaginase. 
2. MATERIALS AND METHODS 
A crystallized asparaginase (L-asparagine 
amidohydrolase, EC 3.5.1.1) from E. coli was 
kindly donated by Kyowa Hakko Kogyo Co. 
(Tokyo). The molar extinction coefficient at 
2’78 nm is 8.53 x lo4 M-’ -cm-‘. HBN was pur- 
chased from Dojin Laboratory (Kumamoto, 
Japan). Other reagents were of anaiytical grade. 
Asparaginase was modified with HNB by the 
method described previously 16-81. The degree of 
modification of tryptophan residues in the 
asparaginase molecule with the reagent was spec- 
trophotometrically determined, and it was found 
that all 4 tryptophan residues in the molecule were 
modified. The modified asparaginase dissociated 
into subunits and lost almost completely the en- 
zymic activity 161. 
Anti-asparaginase serum was obtained from 
rabbit immunized with native asparaginase f9]. 
The IgG fraction was isolated from the serum by 
ammonium sulfate precipitation (35% saturation) 
followed by ion-exchange chromatography with 
DEAE-Sephadex [lo], The Fab fragment was ob- 
tained by digestion of the IgG with papain [1 I]. 
The enzymic activity (hydrolysis of L-asparagine) 
was determined from the amount of released am- 
monia using Nessler reagent. 
3. RESULTS AND DISCUSSION 
Fig. 1 represents the enhancement of the enzymic 
activity of the HNB-modified asparaginase with 
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Fig. 1. Activation of the enzymic activity of HNB- Fig.2. Effect of incubation time of the modified 
modified asparaginase with IgG (A) and its Fab (B). The asparaginase (5 pg) with IgG (53 pg) at 25°C on the 
amount of modified asparaginase, 5 pg. enzymic activity. 
IgG (curve A) and its fragment, Fab (curve B). Ad- 
dition of IgG to the modified asparaginase gave 
rise to a marked increment of the enzymic activity, 
as shown by curve A. The activity reached to the 
maximum level and then gradually decreased by in- 
creasing the concentration of IgG. The maximum 
activity obtained at 53 pg IgG was approx. 
60-times greater than the activity of the modified 
asparaginase in the absence of IgG (0.07 IU/mg 
protein). Enhancement of the enzymic activity of 
the modified asparaginase was also observed in the 
presence of Fab, which is shown by curve B. The 
activity was enhanced with increasing concentra- 
tion of Fab but kept a constant level (2.6 IU/mg 
protein) at higher than 200 pg Fab. The decrease of 
once-enhanced activity with IgG shown by curve A 
can be explained by insolubilization due to the for- 
mation of enzyme-IgG complexes. 
Fig.2 shows the effect of incubation time of the 
modified asparaginase with IgG on the enzymic ac- 
tivity. The activity was enhanced by increasing the 
incubation time. This result was obtained by the 
incubation of 5 pug modified asparaginase with 
53 fig IgG at 25”C, which is an optimal condition 
with the maximum activity (fig.1, curve A). In the 
absence of IgG, the activity was not enhanced by 
incubation at all. Note that enhancement of the en- 
zymic activity of modified asparaginase takes place 
not only with IgG but also with Fab, which was ob- 
tained by immunization of native asparaginase. 
The same phenomenon as above was never ob- 
served with IgG obtained from other antigens uch 
as uricase instead of asparaginase. 
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Since the modified enzyme would interact with 
IgG or Fab to form an antigen-antibody complex, 
a conformational change of the modified enzyme 
takes place, and the active site of the enzyme may 
be partially rearranged to exert the enzymic 
activity. 
Kirschbaum et al. [12] reported that the 
asparaginase molecule (8.6 S) is dissociated into 
subunits (5.6 S and 4.0 S) by the dilution of an 
asparaginase solution. Here, we studied the dilu- 
tion effect on the enzymic activity of asparaginase 
in the presence and absence of Fab. The result is 
shown in table 1. The solution containing 1 mg/ml 
native asparaginase was diluted approx. lo4 times 
Table 1 
Retaining the enzymic activity of asparaginase by Fab 
fragment 
Incubation time 
(min) 
Enzymic activity of asparaginase 
(IU/mg) 
0 
40 
80 
240 
In the In the 
absence of Fab presence of Fab 
156 149 
83 140 
12 141 
2 144 
One mg/ml of native asparaginase was diluted to 
approx. lo4 times (0.09 pg/ml) with phosphate-buffered 
saline (pH 7.0) in the presence and absence of Fab 
(3.6 pg/ml) 
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(0.09 pg/ml) with phosphate-buffered saline (pH 
7.0) with and without Fab. The diluted solution 
was incubated at 25°C. At a given time of incuba- 
tion, the enzymic activity was determined. In the 
absence of Fab, the enzymic activity was markedly 
decreased by increasing the incubation time, pro- 
bably due to dissociation of the asparaginase 
molecule into subunits. On the other hand, the ac- 
tivity was not reduced at all in the presence of Fab. 
From these results, together with the data by 
Kirschbaum et al. [12], it can be said that the 
asparaginase molecule dissociates into subunits, 
accompanied by loss of the enzymic activity. The 
stabilization of asparaginase may be due to the 
protection from dissociation of the molecule into 
subunits with Fab. The activation of the HNB- 
modified asparaginase (monomeric form) by IgG 
or Fab may be attributed to a partial association of 
subunits to form a tetrameric structure. 
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